Factors such as cost, access, and lack of long-term safety data may influence how P-CABs are integrated into practice.

Experts challenge IPC's warning on beta blockers causing low potassium levels, emphasizing their safety and efficacy in ...

Hector Granados, one of two pediatric endocrinologists in El Paso, said he stopped providing gender-affirming care after it ...

The researchers analyzed insurance claims data for 5.1 million youth who fell into the 8–17 age bracket at any point between ...

Alpha- and beta-blockers reduce oxidative stress and inflammation caused by aircraft noise but fail to prevent hypertension, ...

A recent study also found that not a single transgender or gender-diverse child younger than 12, in a group of about 5 million youth studied, received hormones.

“It echoes past work that has found that gender-affirming medical care, including puberty blockers and hormone treatment, is ...

Among privately insured US adolescents who identified as transgender and gender-diverse, receipt of puberty blockers and hormones was rare.

Less than 0.1% of teenagers with private insurance in the United States are receiving gender-related medicines, ...

Less than 0.1% of adolescents in the United States identified as transgender or gender diverse and received puberty blockers ...

Gender-affirming care was rarely provided to minors from 2018 through 2022, according to new research out of Harvard ...

The use of gender-affirming medical care for trans teens was rare between 2018 to 2022, according to a new study published in ...